“High-Cost Drugs”

35 result(s)
Cost Management
White Paper: Current and New Approaches to Making Drugs More Affordable
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker... More
White Paper
Care Management
An Integrated Approach for an Evolving Oncology Landscape
Cancer therapy is evolving and new treatments are being developed at an almost breakneck pace. To help better manage care and costs for oncology, CVS Health has developed an... More
Briefing
Specialty
A Foundational Approach to Specialty Cost Management
CVS Health’s three-tier specialty formulary design separates the increasingly more expensive specialty therapies into three distinct copay or coinsurance categories. Paired with... More
Briefing
Specialty
High-Touch, Whole Patient Care for PAH
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need... More
Briefing
Drug Pipeline
Supplemental Indications Add Uses, Expand Market
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient... More
Briefing
Cost Management
High Drug Prices: Who is Responsible?
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary
Cost Management
The Role of Market Competition in Cost Containment
Our formulary strategies effectively leverage competition in the pharmaceutical market to help reduce costs and trend for PBM clients. More
Video
Drug Pipeline
Managing the Thriving Specialty Pipeline
Scientific developments are altering the pace and focus of specialty drug development, while regulatory changes are shortening approval times. This poses new challenges for payors... More
Briefing
Specialty
New Horizons for PAH Treatments
While the launch time is uncertain, potential PAH generics could give payors greater cost control opportunities for a complex, expensive condition requiring lifelong treatment. More
Briefing
Cost Management
Saving Patients Money
Real-time, member-specific benefit information across all points of care, helps provide greater price transparency, improves access to lower-cost alternatives, and makes... More
Briefing